Page=Gated Download

From shaky to systematic: Optimizing biopharma BD&L activity with comprehensive indication scoping

From shaky to systematic: Optimizing biopharma BD&L activity with comprehensive indication scoping

A guide to finding better-fit BD&L opportunities, faster.

BD&L teams are under increasing pressure to find the right in-licensing and acquisition opportunities quickly, often in unfamiliar therapeutic areas and amid a growing flood of assets. In this complexity, teams can often fall to reactive, ad hoc approaches to BD&L, but this risks wasted time, missed opportunities, and misalignment between end decisions and overall company goals.

To help teams focus their BD&L approach, rule out poor-fit opportunities early, and direct their resources where success is most likely, we’ve put together an in-depth guide.

Download the complete guidebook to learn:

  • The risks of an ad hoc approach to biopharma BD&L
  • A practical, four-step approach to focus and optimize your asset search
  • How to interrogate indication-specific factors to determine whether an opportunity can meet your goals
Section Divider

Ready to help build the future of biopharma strategy?